Back to Journals » Vascular Health and Risk Management » Volume 16

Review

Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan

       
Total article views   HTML views PDF downloads Totals
13,034 Dovepress* 9,015+ 1,845 10,860
PubMed Central* 4,019 768 4,787
Totals 13,034 2,613 15,647
*Since 16 January 2020

View citations on PubMed Central and Google Scholar